MedTrace Logo

Analgesic Protocol With Gabapentin Dexmedetomidine For Postoperative Pain Managment

NCT04976374 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-11-02

No results posted yet for this study

Summary

Assessment of quality of post mastectomy analgesic protocol of Gabapentin and Dexmedetomedine in a placebo-controlled study

Conditions

  • Analgesia

Interventions

DRUG

Dexmedetomidine and Gabapentin

Administration of intravenous dexmedetomedine for post operative analgesic purposes in combination with gabapentin

OTHER

Saline

Intravenous Saline 0.9% for placebo purposes

Sponsors & Collaborators

  • National Cancer Institute, Egypt

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2021-11-25
Completion
2021-11-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04976374 on ClinicalTrials.gov